CHENNAI, India--Aug. 23, 2006--TAKE Solutions, a technology enabled business solutions company with leadership in the Life Sciences and Supply Chain Management verticals today announced an order win from Dabur Pharma Limited, India's leading cancer research and anti-cancer product company and an associate company of Dabur India Limited. TAKE Solutions will implement its flagship product - PharmaReady(TM), part of the recently launched OneClinical product suite which is a web-based information management system specifically designed for the Life Sciences industry.

"The implementation of a fully integrated solution ensuring an appropriate management of our regulatory dossiers and a compliant solution for electronic submission is part of our current strategy to support product development and registrations worldwide" said Dr. Claude Hariton, Dabur's Global Head of Regulatory Affairs and Drug Safety. "It was our confidence in TAKE Solutions' ability to provide us with a single source for regulatory compliant technology solutions that confirmed Dabur's decision to work with them."

Announcing the order win, said Mr. Sridharan, Managing Director, TAKE Solutions, "We are extremely delighted to add a reputed brand like Dabur to our customer portfolio. We are confident that with the implementation of PharmaReady(TM), Dabur will be able to access multiple interface-enabled document authoring, publishing, and electronic submissions resulting in faster and easier document management."

PharmaReady(TM) document management (DMS), integrated with PharmaReady(TM) publishing tool (eCTD), will provide intuitive electronic content assembling with integrated document management and publishing features to support all major regional templates, life cycle management and consolidated submission reviews.

About Dabur

Dabur Pharma Limited is the leading Indian company for cancer research and anticancer products. The company also markets a range of products in the cardiovascular, antibacterial, antidiabetic & digestive segments.

Dabur Pharma Limited, a public limited company incorporated in March 2003, is a US $200 million healthcare company operating in Europe, Latin America, Asia-Pacific and CIS, and in other major markets through its fully owned subsidiary, Dabur Oncology Plc. The Dabur group of companies have a legacy of trust and excellence in the healthcare business.

The fully integrated pharmaceutical business of Dabur Pharma Limited covers the oral & injectable finished dosage forms, and active pharmaceutical ingredients. The Company has world class expertise for the development and manufacture of active pharmaceutical ingredients, intermediates, and finished dosage forms. This expertise enables it to provide high quality and cost effective pharmaceutical products to markets worldwide.

About TAKE Solutions

TAKE Solutions, a technology enabled business solutions company with leadership in Supply Chain Management and Life Sciences, has employee strength of 450. Headquartered in Chennai, the company has its SCM Domain Excellence Centre and Global Delivery Centre in India. It has a strong presence in USA through its Life Sciences Domain Excellence centres located in Princeton, New Jersey; Research Triangle Park (RTP), Raleigh, North Carolina, and Philadelphia, Pennsylvania. Apart from this the company has a significant representation in various regions across the world through its business development offices located in India, Sri Lanka, Singapore, Malaysia and USA. TAKE Solutions' flagship product is TAKE RTE, which is a unique framework combining BPM, workflow management, and application and information integration. Developed on the Microsoft .Net platform, it also provides a composite application development environment. It has a strong technology and domain expertise, using which it offers IT enabled services to its customers worldwide. TAKE is SEI-CMM Level 4 Certified, Microsoft Gold Certified and is a Registered CDISC Solution provider.